Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation: Concordance With Clinical Outcomes

BACKGROUND—: Dalcetrapib effects on cardiovascular outcomes are determined by adenylate cyclase 9 gene polymorphisms. Our aim was to determine whether these clinical end point results are also associated with changes in reverse cholesterol transport and inflammation. METHODS AND RESULTS—: Participan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Circ Cardiovasc Genet
Main Authors: Tardif, Jean-Claude, Rhainds, David, Brodeur, Mathieu, Feroz Zada, Yassamin, Fouodjio, René, Provost, Sylvie, Boulé, Marie, Alem, Sonia, Grégoire, Jean C., L’Allier, Philippe L., Ibrahim, Reda, Guertin, Marie-Claude, Mongrain, Ian, Olsson, Anders G., Schwartz, Gregory G., Rhéaume, Eric, Dubé, Marie-Pierre
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4982759/
https://ncbi.nlm.nih.gov/pubmed/27418594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGENETICS.116.001405
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados